×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VXRT – vaxart, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VXRT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
04:04 pm
vxrt
Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate [Yahoo! Finance]
Low
Report
Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate [Yahoo! Finance]
12/2
04:01 pm
vxrt
Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
Low
Report
Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
11/19
08:00 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/13
04:01 pm
vxrt
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
High
Report
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
11/7
08:00 am
vxrt
Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13
Low
Report
Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13
10/24
08:00 am
vxrt
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
Low
Report
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
10/15
08:00 am
vxrt
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
Low
Report
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
10/2
10:23 am
vxrt
Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer [Yahoo! Finance]
Low
Report
Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
04:52 pm
vxrt
Form 4 Vaxart, Inc. For: Dec 15 Filed by: Lee Phillip E
Medium
Report
Form 4 Vaxart, Inc. For: Dec 15 Filed by: Lee Phillip E
12/5
06:01 am
vxrt
Form 8-K Vaxart, Inc. For: Dec 02
Medium
Report
Form 8-K Vaxart, Inc. For: Dec 02
11/13
04:24 pm
vxrt
Form 10-Q Vaxart, Inc. For: Sep 30
High
Report
Form 10-Q Vaxart, Inc. For: Sep 30
11/13
04:06 pm
vxrt
Form 8-K Vaxart, Inc. For: Nov 13
High
Report
Form 8-K Vaxart, Inc. For: Nov 13
10/8
04:06 pm
vxrt
Form 8-K Vaxart, Inc. For: Oct 08
Low
Report
Form 8-K Vaxart, Inc. For: Oct 08
9/30
05:20 pm
vxrt
Form 8-K Vaxart, Inc. For: Sep 27
Medium
Report
Form 8-K Vaxart, Inc. For: Sep 27
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/31
Vaxart Announces Initiation of Coronavirus Vaccine Program
43.7%
2/26 Vaxart Inc (NASDAQ: VXRT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 31.2%
4/24 Form DEFA14A Vaxart, Inc. 20.0%
8/8 Q2/2019 6/30/2019 EPS -0.390 ZacksConsensus -0.500 ActVsEst 0.110 - Beat 19.0%
9/27 Form POS AM Vaxart, Inc. 18.6%
4/14 Form 8-K Vaxart, Inc. For: Apr 13 15.3%
2/1 Vaxart Inc (NASDAQ: VXRT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 14.4%
1/22 Results from Influenza Challenge Study Published in Lancet Infectious Diseases 13.4%
11/22 Form SC 13D/A Vaxart, Inc. Filed by: ARMISTICE CAPITAL, LLC 11.8%
4/21 Thinking about buying stock in Carnival Corp, MGM Resorts, Teekay Tankers, Uber, or Vaxart? 10.9%
2/26 Vaxart Inc (NASDAQ: VXRT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 31.2%
4/24 Form DEFA14A Vaxart, Inc. 20.0%
8/8 Q2/2019 6/30/2019 EPS -0.390 ZacksConsensus -0.500 ActVsEst 0.110 - Beat 19.0%
9/27 Form POS AM Vaxart, Inc. 18.6%
4/14 Form 8-K Vaxart, Inc. For: Apr 13 15.3%
2/1 Vaxart Inc (NASDAQ: VXRT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 14.4%
1/22 Results from Influenza Challenge Study Published in Lancet Infectious Diseases 13.4%
11/22 Form SC 13D/A Vaxart, Inc. Filed by: ARMISTICE CAPITAL, LLC 11.8%
4/21 Thinking about buying stock in Carnival Corp, MGM Resorts, Teekay Tankers, Uber, or Vaxart? 10.9%
TOP News Decliners
9/25
Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study
-49.1%
4/30 Vaxart Inc (NASDAQ: VXRT) had its price target raised by analysts at HC Wainwright from $3.00 to $7.00. -22.0%
3/19 Vaxart Inc (NASDAQ: VXRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. -17.9%
9/11 Form S-1 Vaxart, Inc. -15.1%
4/28 Vaxart Announces Corporate Update for First Quarter 2020 -13.9%
9/26 Vaxart Announces Pricing of $8 Million Underwritten Public Offering -13.2%
3/19 Form 8-K Vaxart, Inc. For: Mar 18 -12.2%
3/18 IMV up 53% premarket on coronavirus vaccine plan [Seeking Alpha] -9.7%
2/11 Form SC 13G/A Vaxart, Inc. Filed by: BML Investment Partners, L.P. -8.5%
4/29 Form 8-K Vaxart, Inc. For: Apr 28 -8.3%
4/30 Vaxart Inc (NASDAQ: VXRT) had its price target raised by analysts at HC Wainwright from $3.00 to $7.00. -22.0%
3/19 Vaxart Inc (NASDAQ: VXRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. -17.9%
9/11 Form S-1 Vaxart, Inc. -15.1%
4/28 Vaxart Announces Corporate Update for First Quarter 2020 -13.9%
9/26 Vaxart Announces Pricing of $8 Million Underwritten Public Offering -13.2%
3/19 Form 8-K Vaxart, Inc. For: Mar 18 -12.2%
3/18 IMV up 53% premarket on coronavirus vaccine plan [Seeking Alpha] -9.7%
2/11 Form SC 13G/A Vaxart, Inc. Filed by: BML Investment Partners, L.P. -8.5%
4/29 Form 8-K Vaxart, Inc. For: Apr 28 -8.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: